ArticleMaterials (Basel, Switzerland)2023
Influence of Fiber Type and Dosage on Tensile Property of Asphalt Mixture Using Direct Tensile Test.
Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 11 citations in OpenAlex.
- An Experimental Study on the Influence of Waste Tyre Metal Fibre on Asphalt Mixture's Performance Properties.Materials (Basel, Switzerland) · 2026Article
- SMA-13 Recycled Asphalt Mixtures with Flocculent Basalt Fiber: Experiment and Random Forest Analysis.Materials (Basel, Switzerland) · 2026Article
- Research on the Influence of Fibers on the Mechanical Properties of Asphalt Mixtures.Materials (Basel, Switzerland) · 2025Article
- Characterization, Applications and New Technologies of Civil Engineering Materials and Structures.Materials (Basel, Switzerland) · 2024Article
- Bonding Mechanical Properties between SMA Fiber and ECC Matrix under Direct Pullout Loads.Materials (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
In engineering practice, fiber addition is a frequently used method to improve the tensile property of asphalt mixture. However, the optimum fiber type and dosage have not been determined by direct tensile tests. In this paper, monotonic tensile tests were conducted on three kinds of stone mastic asphalt (SMA13) mixtures, that is, granular-lignin-fiber-reinforced SMA (GFSMA), flocculent-lignin-fiber-reinforced SMA (FFSMA), and basalt-fiber-reinforced SMA (BFSMA) at different fiber dosages to probe the influence of fiber dosage on their tensile mechanical indexes (tensile strength, ultimate strain, elastic modulus, and strain energy density) and to determine the optimum dosage of each kind of fiber. The results showed that with the elevation of fiber dosage, the tensile strength, elastic modulus, and strain energy density of all three kinds of asphalt mixtures increased first and then decreased, while the ultimate strain increased constantly. The optimum dosage was 0.50 wt%, 0.45 wt%, and 0.50 wt% for granular lignin fiber, flocculent lignin fiber, and basalt fiber, respectively. On this basis, strain-controlled direct tensile fatigue tests were conducted on the three kinds of asphalt mixtures at the corresponding optimum fiber dosage. The results indicated that asphalt mixture reinforced with 0.50 wt% granular lignin fiber exhibited ideal direct tensile fatigue performance with respect to fatigue life and accumulative dissipated energy. Therefore, granular lignin fiber is recommended as the favorable fiber type, and its optimum dosage is 0.50 wt%. Moreover, scanning electron microscopy (SEM) demonstrated that the essence of the impact of fiber dosage and type on the tensile property of SMA is whether the reinforcement effect on the mixture matrix outweighs the negative effect of the defects between fiber and mixture matrix, or whether the reverse applies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.